Advanced search
Publication Cover
Journal of Enzyme Inhibition and Medicinal Chemistry Volume 35, 2020 - Issue 1
Submit an article Journal homepage
6,334
Views
49
CrossRef citations to date
0
Altmetric
Review Article

DNA topoisomerases as molecular targets for anticancer drugs

Kamila Buzuna Department of Biotechnology, Medical University of Bialystok, Bialystok, PolandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5030-2862View further author information
ORCID Icon,
Anna Bielawskaa Department of Biotechnology, Medical University of Bialystok, Bialystok, PolandORCID Iconhttps://orcid.org/0000-0001-9164-8440View further author information
ORCID Icon,
Krzysztof Bielawskib Department of Synthesis and Technology of Drugs, Medical University of Bialystok, Bialystok, PolandORCID Iconhttps://orcid.org/0000-0003-3187-4205View further author information
ORCID Icon &
Agnieszka Gornowicza Department of Biotechnology, Medical University of Bialystok, Bialystok, PolandORCID Iconhttps://orcid.org/0000-0002-0945-7870View further author information
ORCID Icon
Pages 1781-1799 | Received 07 Jul 2020, Accepted 02 Sep 2020, Published online: 25 Sep 2020

Citations (49)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Hadeer K. Swedan, Asmaa E. Kassab, Ehab M. Gedawy & Salwa E. Elmeligie. (2023) Design, synthesis, and biological evaluation of novel ciprofloxacin derivatives as potential anticancer agents targeting topoisomerase II enzyme. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1, pages 118-137.
Read now
Sefa Celik, Sevim Akyuz & Aysen E. Ozel. (2023) Molecular modeling, DFT quantum chemical analysis, and molecular docking on edotecarin, an indolocarbazole anticancer agent. Molecular Crystals and Liquid Crystals 753:1, pages 27-49.
Read now
Muhammad Sohail, Zheng Sun, Yanli Li, Xuejing Gu & Hui Xu. (2021) Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy. Expert Review of Anticancer Therapy 21:12, pages 1385-1398.
Read now

Articles from other publishers (46)

Parampreet Kour, Pallavi Saha, Deepak K. Sharma & Kuljit Singh. (2024) DNA topoisomerases as a drug target in Leishmaniasis: Structural and mechanistic insights. International Journal of Biological Macromolecules 256, pages 128401.
Crossref
Xin-Wei Li, Shu-Jun Fang, Ying-Ze Li, Li-Qing Qin, Nan-Ying Chen, Bin Zheng, Dong-Liang Mo, Gui-Fa Su, Jun-Cheng Su & Cheng-Xue Pan. (2023) Design and synthesis of luotonin A-derived topoisomerase targeting scaffold with potent antitumor effect and low genotoxicity. Bioorganic Chemistry, pages 107015.
Crossref
Manpreet Kaur, Prabhat Suman, Sahil Arora, Tashvinder Singh, Anjana Munshi, Sandeep Singh & Raj Kumar. (2023) Design, Synthesis, and Anticancer Evaluation of Hemithioindigos via Inhibition of Human Topoisomerases. ChemistrySelect 8:41.
Crossref
Sawssen Souiei, Jalloul Bouajila, Ilyes Saidi, Mansour Znati, Hichem Ben Jannet & Fatima El Garah. (2023) Synthesis, in vitro and in silico evaluation of new flavonoids-trifluoroacetylated amino acid conjugates as anti-acetylcholinesterase and anti-proliferative agents. Journal of Molecular Structure 1292, pages 136180.
Crossref
Sandeep Goyal, Mukesh Gangar, Aditya Kulkarni & Charu Kamal Yerneni. 2023. Alternative Remedies and Natural Products for Cancer Therapy: An Integrative Approach. Alternative Remedies and Natural Products for Cancer Therapy: An Integrative Approach 165 182 .
Ali Khoshnood, Nafiseh Farhadian, Khalil Abnous, Maryam M. Matin, Nasrin Ziaee & Elnaz Yaghoobi. (2023) N doped-carbon quantum dots with ultra-high quantum yield photoluminescent property conjugated with folic acid for targeted drug delivery and bioimaging applications. Journal of Photochemistry and Photobiology A: Chemistry 444, pages 114972.
Crossref
Fayez Althobaiti, Heba A. Sahyon, Mai M.A.H. Shanab, Adil Aldhahrani, Marihan A. Helal, Awad Khireldin, Abdel Ghany F. Shoair, Abdulraheem S.A. Almalki & Ahmed M. Fathy. (2023) A comparative study of novel ruthenium(III) and iron(III) complexes containing uracil; docking and biological studies. Journal of Inorganic Biochemistry 247, pages 112308.
Crossref
Taixiang Wang, Alastair H. Kyle, Jennifer H. E. Baker, Nannan A. Liu, Judit P. Banáth & Andrew I. Minchinton. (2023) DNA-PK inhibition extends the therapeutic effects of Top2 poisoning to non-proliferating cells, increasing activity at a cost. Scientific Reports 13:1.
Crossref
Bratati De. 2023. Chemical Diversity of Plant Specialized Metabolites. Chemical Diversity of Plant Specialized Metabolites 163 217 .
Manar M. Abuzahra, Nesreen S. Ahmed, Mona O. Sarhan, Shahenda Mahgoub, Ahmed Abdelhameed & Wafaa A. Zaghary. (2023) Novel substituted 1,8‐naphthyridines: Design, synthesis, radiolabeling, and evaluation of apoptosis and topoisomerase II inhibition. Archiv der Pharmazie 356:7.
Crossref
Maria Stefania Sinicropi, Jessica Ceramella, Patrice Vanelle, Domenico Iacopetta, Camillo Rosano, Omar Khoumeri, Shawkat Abdelmohsen, Wafaa Abdelhady & Hussein El-Kashef. (2023) Novel Thiazolidine-2,4-dione-trimethoxybenzene-thiazole Hybrids as Human Topoisomerases Inhibitors. Pharmaceuticals 16:7, pages 946.
Crossref
Muhammed Tilahun Muhammed, Mustafa ER & Senem Akkoc. (2023) Molecular modeling and in vitro antiproliferative activity studies of some imidazole and isoxazole derivatives. Journal of Molecular Structure 1282, pages 135066.
Crossref
Jung Yoon Jang, Donghwan Kim & Nam Deuk Kim. (2023) Recent Developments in Combination Chemotherapy for Colorectal and Breast Cancers with Topoisomerase Inhibitors. International Journal of Molecular Sciences 24:9, pages 8457.
Crossref
Izabela Jęśkowiak-Kossakowska, Paulina Jawień, Edward Krzyżak, Marcin Mączyński, Roman Szafran, Adam Szeląg, Maciej Janeczek & Benita Wiatrak. (2023) Search for immunomodulatory compounds with antiproliferative activity against melanoma. Biomedicine & Pharmacotherapy 160, pages 114374.
Crossref
Jeremy M. Kelm, Deepti S. Pandey, Evan Malin, Hussein Kansou, Sahil Arora, Raj Kumar & Navnath S. Gavande. (2023) PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy. Molecular Cancer 22:1.
Crossref
Mohamed A. Elanany, Essam Eldin A. Osman, Ehab Mohamed Gedawy & Sahar M. Abou-Seri. (2023) Design and synthesis of novel cytotoxic fluoroquinolone analogs through topoisomerase inhibition, cell cycle arrest, and apoptosis. Scientific Reports 13:1.
Crossref
Jan Benada, Dalal Alsowaida, Lynn A. Megeney & Claus S. Sørensen. (2023) Self-inflicted DNA breaks in cell differentiation and cancer. Trends in Cell Biology.
Crossref
Domenico Iacopetta, Jessica Ceramella, Noemi Baldino, Maria Sinicropi & Alessia Catalano. (2023) Targeting Breast Cancer: An Overlook on Current Strategies. International Journal of Molecular Sciences 24:4, pages 3643.
Crossref
Cosmas O. Okoro & Toluwase Hezekiah Fatoki. (2023) A Mini Review of Novel Topoisomerase II Inhibitors as Future Anticancer Agents. International Journal of Molecular Sciences 24:3, pages 2532.
Crossref
Lishuo Zhang, Longjiang Di, Jinhui Liu, Xianli Lei, Maoli Gu, Wenjing Zhang & Yufu Wang. (2023) The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma. Frontiers in Genetics 14.
Crossref
Giuliano Gattoni, Rafael R. de la Haba, Jesús Martín, Fernando Reyes, Cristina Sánchez-Porro, Antonia Feola, Candida Zuchegna, Shaday Guerrero-Flores, Mario Varcamonti, Ezio Ricca, Nelly Selem-Mojica, Antonio Ventosa & Paulina Corral. (2023) Genomic study and lipidomic bioassay of Leeuwenhoekiella parthenopeia: A novel rare biosphere marine bacterium that inhibits tumor cell viability. Frontiers in Microbiology 13.
Crossref
Vishal Singh, Tayyaba Afshan, Pankaj Tyagi, Pritish Kumar Varadwaj & Amaresh Kumar Sahoo. (2023) Recent development of multi-targeted inhibitors of human topoisomerase II enzyme as potent cancer therapeutics. International Journal of Biological Macromolecules 226, pages 473-484.
Crossref
Kavya Kondaka & Iwona Gabriel. (2022) Targeting DNA Topoisomerase II in Antifungal Chemotherapy. Molecules 27:22, pages 7768.
Crossref
Thoraya A. Farghaly, Hanan Gaber Abdulwahab, Hanadi Y. Medrasi, Mariam A. Al-sheikh, Dina F. Katowah & Amani M.R. Alsaedi. (2022) Novel 6,7,8-trihydrobenzo[6',7']cyclohepta[2',1'-e]pyrazolo[2,3-a]pyrimidine derivatives as Topo IIα inhibitors with potential cytotoxic activity. Bioorganic Chemistry 128, pages 106043.
Crossref
Giulia Greco, Valentina Pellicioni, Ivan Cruz-Chamorro, Giuseppe Attisani, Claudio Stefanelli & Carmela Fimognari. (2022) Marine-Derived Compounds Targeting Topoisomerase II in Cancer Cells: A Review. Marine Drugs 20:11, pages 674.
Crossref
Gleyton Sousa, Maria C. F. de Almeida, Lucas L. Lócio, Vanda L. dos Santos, Daniel P. Bezerra, Valdenizia R. Silva, Sinara M. V. de Almeida, Alice Simon, Thiago da S. Honório, Lucio M. Cabral, Rosane N. Castro, Ricardo O. de Moura & Arthur E. Kümmerle. (2022) Synthesis and Evaluation of Antiproliferative Activity, Topoisomerase IIα Inhibition, DNA Binding and Non-Clinical Toxicity of New Acridine–Thiosemicarbazone Derivatives. Pharmaceuticals 15:9, pages 1098.
Crossref
Eman Zekry Attia, Basma Ali Khalifa, Gehan M. Shaban, Mohamed N. Amin, Lina Akil, Ibrahim Khadra, Ahmed A. Al Karmalawy, Radwan Alnajjar, Marco Y.W. Zaki, Omar M. Aly, Mo'men H. El-Katatny & Usama Ramadan Abdelmohsen. (2022) Potential topoisomerases inhibitors from Aspergillus terreus using virtual screening. South African Journal of Botany 149, pages 632-645.
Crossref
Mehdi Eshraghi, Mazaher Ahmadi, Saeid Afshar, Shahrokh Lorzadeh, Aida Adlimoghaddam, Nahid Rezvani Jalal, Ryan West, Sanaz Dastghaib, Somayeh Igder, Seyed Reza Naeimi Torshizi, Amir Mahmoodzadeh, Pooneh Mokarram, Tayyebeh Madrakian, Benedict C. Albensi, Marek J. Łos, Saeid Ghavami & Stevan Pecic. (2022) Enhancing autophagy in Alzheimer's disease through drug repositioning. Pharmacology & Therapeutics 237, pages 108171.
Crossref
Smita Kumari, Sudhanshu Sharma, Dia Advani, Akanksha Khosla, Pravir Kumar & Rashmi K. Ambasta. (2021) Unboxing the molecular modalities of mutagens in cancer. Environmental Science and Pollution Research 29:41, pages 62111-62159.
Crossref
Stefano MastrangeloGiorgio AttinaSilvia TriaricoAlberto RomanoPalma MauriziAntonio Ruggiero. (2022) The DNA-topoisomerase Inhibitors in Cancer Therapy. Biomedical and Pharmacology Journal 15:2, pages 553-562.
Crossref
Sreepriya M Sreepriya M, Bhimnaik S Bhimnaik S, Bhavyasai Bhavyasai, Rumana A Rumana A & Divya M Divya M. (2022) Antiproliferative Effects of Phytoestrogens Formononetin and Resveratrol Against Human Pulmonary Adenocarcinoma Cells A 549. Biosciences Biotechnology Research Asia 19:2, pages 309-319.
Crossref
Marina P. Kiseleva, Larisa M. Borisova, Galina B. Smirnova, Yulia A. Borisova, Anna V. Lantsova, Ekaterina V. Sanarova, Lyudmila L. Nikolaeva, Lydia V. Ektova & Marina V. Komarova. (2022) Antiproliferative activity of a new derivative from the class of N-glycoside of indolo[2,3-a]pyrrolo[3,4-c]carbazoles. Research Results in Pharmacology 8:2, pages 49-57.
Crossref
Rosemeyre Cordeiro, Ana Carvalho, Luísa Durães & Henrique Faneca. (2022) Triantennary GalNAc-Functionalized Multi-Responsive Mesoporous Silica Nanoparticles for Drug Delivery Targeted at Asialoglycoprotein Receptor. International Journal of Molecular Sciences 23:11, pages 6243.
Crossref
Fatma Zilifdar Foto, Egemen Foto, Tugba Ertan-Bolelli & Ilkay Yildiz. (2022) Biological activity and ADME/Tox prediction of some 2-substituted benzoxazole derivatives. Bioorganic Chemistry 123, pages 105756.
Crossref
Rong-jia Shi, Hua-yang Fan, Xiang-hua Yu, Ya-ling Tang, Jian Jiang & Xin-hua Liang. (2022) Advances of podophyllotoxin and its derivatives: Patterns and mechanisms. Biochemical Pharmacology 200, pages 115039.
Crossref
Kamila Buzun, Agnieszka Gornowicz, Roman Lesyk, Anna Kryshchyshyn-Dylevych, Andrzej Gzella, Robert Czarnomysy, Gniewomir Latacz, Agnieszka Olejarz-Maciej, Jadwiga Handzlik, Krzysztof Bielawski & Anna Bielawska. (2022) 2-{5-[(Z,2Z)-2-Chloro-3-(4-nitrophenyl)-2-propenylidene]-4-oxo-2-thioxothiazolidin-3-yl}-3-methylbutanoic Acid as a Potential Anti-Breast Cancer Molecule. International Journal of Molecular Sciences 23:8, pages 4091.
Crossref
Rosemeyre A. Cordeiro, Patrícia V. Mendonça, Jorge Coelho & Henrique Faneca. (2022) Engineering silica-polymer hybrid nanosystems for dual drug and gene delivery. Biomaterials Advances 135, pages 212742.
Crossref
Parisa Zargar, Shabnaz Koochakkhani, Marziyeh Hassanzadeh, Yaghoub Ashouri Taziani, Hamid Nasrollahi & Ebrahim Eftekhar. (2022) Downregulation of topoisomerase 1 and 2 with acriflavine sensitizes bladder cancer cells to cisplatin-based chemotherapy. Molecular Biology Reports 49:4, pages 2755-2763.
Crossref
Maria Kozurkova. (2021) Acridine derivatives as inhibitors/poisons of topoisomerase II. Journal of Applied Toxicology 42:4, pages 544-552.
Crossref
Kamila Rząd, Ewa Paluszkiewicz, Damian Neubauer, Mateusz Olszewski, Katarzyna Kozłowska-Tylingo, Wojciech Kamysz & Iwona Gabriel. (2021) The Effect of Conjugation with Octaarginine, a Cell-Penetrating Peptide on Antifungal Activity of Imidazoacridinone Derivative. International Journal of Molecular Sciences 22:24, pages 13190.
Crossref
Yichao Wan, Guoqing Fang, Hongjuan Chen, Xu Deng & Zilong Tang. (2021) Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation. European Journal of Medicinal Chemistry 226, pages 113837.
Crossref
Afaf El-Malah, Amira Youssef, Mohamed Ismail, Mona Kamel & Zeinab Mahmoud. (2021) New promising levofloxacin derivatives: Design, synthesis, cytotoxic activity screening, Topo2β polymerase inhibition assay, cell cycle apoptosis profile analysis. Bioorganic Chemistry 113, pages 105029.
Crossref
Esin Karatas, Egemen Foto, Tugba Ertan-Bolelli, Gozde Yalcin-Ozkat, Serap Yilmaz, Sanaz Ataei, Fatma Zilifdar & Ilkay Yildiz. (2021) Discovery of 5-(or 6)-benzoxazoles and oxazolo[4,5-b]pyridines as novel candidate antitumor agents targeting hTopo IIα. Bioorganic Chemistry 112, pages 104913.
Crossref
Kseniya Kovaleva, Olga Yarovaya, Konstantin Ponomarev, Sergey Cheresiz, Amirhossein Azimirad, Irina Chernyshova, Alexandra Zakharenko, Vasily Konev, Tatiana Khlebnikova, Evgenii Mozhaytsev, Evgenii Suslov, Dmitry Nilov, Vytas Švedas, Andrey Pokrovsky, Olga Lavrik & Nariman Salakhutdinov. (2021) Design, Synthesis, and Molecular Docking Study of New Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors Combining Resin Acids and Adamantane Moieties. Pharmaceuticals 14:5, pages 422.
Crossref
Suélen Karine Sartori, Marisa Alves Nogueira Diaz & Gaspar Diaz-Muñoz. (2021) Lactones: Classification, synthesis, biological activities, and industrial applications. Tetrahedron 84, pages 132001.
Crossref
Wen-Yun Hsueh, Ying-Shuan E. Lee, Min-Sian Huang, Chin-Hung Lai, Yu-Sheng Gao, Jo-Chu Lin, Yu-Fen Chen, Chih-Lin Chang, Shan-Yen Chou, Shyh-Fong Chen, Yann-Yu Lu, Lien-Hsiang Chang, Shu Fu Lin, Yu-Hsiang Lin, Pi-Chen Hsu, Win-Yin Wei, Ya-Chi Huang, Yi-Feng Kao, Li-Wei Teng, Hung-Huang Liu, Ying-Chou Chen, Ta-Tung Yuan, Ya-Wen Chan, Po-Hsun Huang, Yu-Ting Chao, Shin-Yi Huang, Bo-Han Jian, Hsin-Yi Huang, Sheng-Chuan Yang, Tzu-Hao Lo, Guan-Ru Huang, Shao-Yun Wang, Her-Sheng Lin, Shih-Hsien Chuang & Jiann-Jyh Huang. (2021) Copper(I)-Catalyzed Nitrile-Addition/ N -Arylation Ring-Closure Cascade: Synthesis of 5,11-Dihydro-6 H -indolo[3,2- c ]quinolin-6-ones as Potent Topoisomerase-I Inhibitors . Journal of Medicinal Chemistry 64:3, pages 1435-1453.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.